Stock Movers: Palantir Slides, Constellation Energy Surges on Nuclear Deals, Hims & Hers Rises

Palantir's AI Stock Correction

• 📉 Palantir Technologies (PLTR) stock closed down 12%, marking its worst drop in nearly a year.
• 💡 Despite beating earnings and raising its 2025 revenue forecast to $3.9 billion, the stock's performance was deemed insufficient to justify its high valuation.
• 📊 Analysts noted that while the US commercial segment growth is strong (68%), revisions might be muted due to limited traction in the international division.
• 🚀 Palantir was previously the best-performing stock in the S&P 500 year-to-date, highlighting its popularity in the AI and momentum trade.

Constellation Energy's Nuclear Power Push

• ⚡ Constellation Energy (CEG) shares surged 10% to their highest level since February, driven by news of nearing long-term nuclear power deals.
• 🎯 These deals are intended to meet the growing demand for energy to power data centers and factories, particularly those involved in AI operations.
• 📈 The company's CEO highlighted that these agreements strengthen the case for its pending $16.4 billion acquisition of Calpine.
• ⚠️ Although Constellation's first-quarter profit fell short of expectations, the market reacted positively to the prospect of significant nuclear power agreements.

Hims & Hers Health Rebounds

• 📈 Hims & Hers Health Inc. (HIMS) saw an 18% stock increase following better-than-expected first-quarter results.
• 💰 The telehealth company reported revenue of $586 million, surpassing estimates of $538 million, with sales up 111%.
• 💊 Hims & Hers is shifting its strategy from selling compounded weight-loss drugs to offering discounted versions of branded drugs like Novo Nordisk's Wegovy.
• 📊 While the earnings were impressive, analyst sentiment remains mixed, with a majority of ratings being 'hold' rather than 'buy'.